Project ECHO at the University of Minnesota

• Project ECHOWorkshop
• Navigating School Spirit
• Multi-Tiered Systems of Support (MTSS)
• Supporting Children with Challenging Behavior Sprint
• Autism Spectrum Disorder Sprint

• My Role in Equity & Diversity
• Addressing Implicit Bias and Microaggressions
• Navigating Challenging Conversations
• Removing Barriers and Creating Access
• Ableism & Disability Justice    
• Challenging Classism    
• Gender, Gender Identity, and Sexuality        
• Race and Racism
• Religious and Spiritual Identities    
• Understanding and Addressing Gender-Based Oppression    
• Sizeism & the Fat Liberation Movement
• Addressing Xenophobia & Marginalization of International Community Members

• Forensic Nurse Program Leaders Connection

2026

• The Application of Pharmacogenomics in the Treatment of ADHD, University of Florida

2025

•  Geritom Medical Inc., Reuse of Pharmacogenomic Test Results in Long-Term Care, University of Minnesota 
•  CYP1A2 Genetic Variation, Smoking Induction and Duloxetine, Essentia Health
•  Beyond the Guidelines - Dissecting Pharmacogenomics in Marfan Syndrome, St. Elizabeth Healthcare
•  Using Pharmacogenomics in Family Medicine with Pediatric Populations, University of Pittsburgh
•  Depression and Anxiety Management in Primary Care, Trinity Health / Ferris State University
•  Implications of Gastric Bypass Surgery and Pharmacogenomics on Medication Response, Mayo Clinic
•  "But my dogtags say..." Applications of G6PD Results in Veterans, Kansas City VA
•  Application of Pharmacogenomics in Geriatric Pain Management and Statin Therapy, The Deprescribing Clinic, LLC
•  When Genetics Affect Chemotherapy: Predicting fluoropyrimidine toxicity with DPYD testing, Penn Medicine
•  Twice the power: using pharmacogenomics to tailor therapy of antidepressants, St. Jude Children's Research Hospital
•  Pharmacogenomics and Cardiac Toxicities of Tyrosine Kinase Inhibitors, Indiana University School of Medicine
•  Postural Orthostatic Tachycardia Syndrome (POTS) and the Pharmacogenomic Implications of SSRIs and SNRIs, University of Florida

2024

•  Genetics of Drug-Induced QT Prolongation: What to do in the absence of clinical guidelines?, St. Elizabeth Healthcare
•  Pharmacogenetic Insights into Statin-Induced Rhabdomyolysis, Sanford Health
•  Utilizing Pharmacogenomics in Ambulatory Psychiatry Clinics, University of Michigan / Michigan Medicine
•  The Role of Pharmacogenomics in Anti-Seizure Medications: Optimizing Medication Therapy Management in a PGx Clinic, Sanford Health
•  Potential Escitalopram Related Serotonin Syndrome and Withdrawal, University of Minnesota
•  Factor V Leiden and its Significance for Pharmacogenomics, Nicklaus Children's Hospital
•  Clinical Benefits of CYP Inhibitors
  Tracy Sandritter, PharmD, BCPPS + Alexa Pagano, MD, Children's Mercy
• Clinical Considerations for A Lesser Known Drug-Gene Interaction: Metoclopramide-CYP2D6, Sanford Health
•  A Tamoxifen Case and the Implications of CYP2D6 Phenotype, Minneapolis VA
•  Behavioral and Pain Pharmacogenomics Testing for Patients with Ehlers-Danlos Syndrome, Children's Hospital Los Angeles
•  Antipsychotic Pharmacogenomics: Implications for long-acting injectable formulations, Children's Minnesota + University of Minnesota

• How can we aid residents in emergency situations?
• How might 2026 rules and policies change our work?
• To admit or not to admit: what if we don't agree on admissions?

• What is our role in legislative advocacy?
• How can we improve our staff performance review process?
• Delirium vs. Dementia: How do we differentiate and why does it matter?
• My resident is delirious - now what do I do?
• Beyond Bingo: What are innovative approaches to recreational therapy?
• How do I conduct a great maltreatment interview?
• From training requirements to knife fights, what should we know about de-escalation?
• What aren't we seeing in vision assessments?
• What do my pool agency staff need to know before they go on the floor?
• My resident can't make decisions now - what are my options?
• What is the impact of heat on resident health?
• Whose decision is it: how do we balance autonomy vs. safety?
• Who can complete respiratory evaluations?
• Put me in, Coach! Who do we have helping people after they onboard?
• What if we aren't able to take a resident back from the hospital due to acuity changes?
• Are we ready for respiratory illness season?
• What lies ahead for artificial intelligence (AI) in aging services?
• Board Licensure Inquiries: How to Respond in Challenging Times
• How do I respond to resident harassment of employees?
• Do we really need to talk about oral health?
• How do we coordinate better with hospice providers?
• What do we need to know about survey readiness trends from 2025?